Vic A. Narurkar
Bay Area Laser Institute, San Francisco, CA, and Department of Dermatology, University of California Davis School of Medicine, Sacremento, CA, USA
13.1 |
Introduction |
281 |
13.2 |
Lasers and Light-Based Systems |
282 |
13.3 |
Ablative Laser Resurfacing |
282 |
13.4 |
Nonablative Skin Resurfacing |
283 |
13.5 |
Photodynamic Therapy |
283 |
13.6 |
Photopneumatic Therapy |
284 |
13.7 |
Nonablative and Ablative Fractional Resurfacing |
284 |
13.8 |
Botulinum Toxins |
286 |
13.9 |
Dermal Fillers |
287 |
13.10 |
Conclusions |
287 |
Suggested Reading |
288 |
|
13.1 |
Introduction |
The last decade has witnessed an unparalleled growth in the demand for nonsurgical procedures. This trend is a result of numerous advances in devices, fillers, and botulinum |
Gurpreet S. Ahluwalia (ed.), Cosmetic Applications of Laser and Light-Based Systems, 281-289,
© 2009 William Andrew Inc.
toxins, in addition to an aging population. It is becoming increasingly evident that, while each modality, when used in monotherapy, may produce satisfactory clinical outcomes, combination therapies with multiple modalities are often necessary for optimal patient satisfaction. Devices are best for addressing anomalies of the facial canvas, dermal fillers are best for addressing facial volume loss, and neurotoxins are best for addressing dynamic facial lines of expression. There is some evidence that a synergy probably exists between these modalities, even at an ultrastructural level. This chapter will review combination therapies with lasers and light, dermal fillers, and botulinum toxins.